<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03276923</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00084014</org_study_id>
    <nct_id>NCT03276923</nct_id>
  </id_info>
  <brief_title>Maternal Autoimmune Disease Research Alliance (MADRA) Registry</brief_title>
  <acronym>MADRA</acronym>
  <official_title>Maternal Autoimmune Disease Research Alliance (MADRA) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-site registry, centered at Duke University, will enroll pregnant women with&#xD;
      autoimmune and rheumatologic diseases.&#xD;
&#xD;
      The main goal of MADRA is to identify ways to improve the health of women with rheumatic&#xD;
      diseases and their babies during pregnancy.&#xD;
&#xD;
      Prior studies demonstrate the importance of increase inflammation prior to and during&#xD;
      pregnancy on these outcomes. The future research will seek to better define these risk&#xD;
      factors and to identify ways to may improve them.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At each site, the patients will be under the care of the participating rheumatologist and&#xD;
      their local obstetrician during the pregnancy. This is a natural-history study and will not&#xD;
      include medications, laboratory testing, or procedures outside of the standard of care.&#xD;
&#xD;
      Management of the rheumatologic disease will be directed based on patient needs by the local&#xD;
      rheumatologist and obstetrician. Enrollment in the registry will not dictate specific&#xD;
      therapy. The Registry will include data from each office visit during pregnancy and up to 12&#xD;
      months after delivery.&#xD;
&#xD;
      The registry will be ongoing, with periodic analysis of clinical data samples as specific&#xD;
      studies are approved.&#xD;
&#xD;
      Enrollment in the registry does not significantly increase risks for a patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>100 Years</target_duration>
  <primary_outcome>
    <measure>Risk factors associated with poor pregnancy outcomes as measured by the MADRA-DAP questionnaire.</measure>
    <time_frame>up to 10 years</time_frame>
    <description>The investigators will ask the participants questions from the MADRA-DAP questionnaire to determine poor pregnancy outcomes.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Autoimmune Diseases</condition>
  <condition>Pregnancy Related</condition>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Cutaneous Lupus</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Sjogren's Syndrome</condition>
  <condition>Scleroderma</condition>
  <arm_group>
    <arm_group_label>Maternal Autoimmune Disease ReseArch (MADRA) Registry</arm_group_label>
    <description>Women with autoimmune diseases who are pregnant</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and urine samples will be collected.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women who have been diagnosed with an autoimmune disease or a rheumatic condition.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Desire for pregnancy within 6 months or currently pregnant&#xD;
&#xD;
          -  Women with systemic autoimmune disease, including:&#xD;
&#xD;
          -  Lupus (systemic lupus erythematosus or cutaneous lupus)&#xD;
&#xD;
          -  Antiphospholipid Syndrome or positive antiphospholipid antibodies&#xD;
&#xD;
          -  Rheumatoid Arthritis&#xD;
&#xD;
          -  Scleroderma (systemic sclerosis)&#xD;
&#xD;
          -  Sjogren's Syndrome&#xD;
&#xD;
          -  Inflammatory Arthritis (including Psoriatic Arthritis and Ankylosing Spondylitis)&#xD;
&#xD;
          -  Undifferentiated Connective Tissue Disease (UCTD)&#xD;
&#xD;
          -  Vasculitis&#xD;
&#xD;
          -  Myositis (Polymyositis or Dermatomyositis)&#xD;
&#xD;
          -  Positive Ro/SSA or La/SSB antibodies&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to speak English&#xD;
&#xD;
          -  Unable to provide informed consent&#xD;
&#xD;
          -  Unable to travel to Duke University for follow-up visits&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megan EB Clowse, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Neil</last_name>
    <phone>919 684 8936</phone>
    <email>laura.k.neil@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Edna Scarlett</last_name>
    <phone>919-684-6150</phone>
    <email>edna.scarlett@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Clowse, MD</last_name>
      <phone>919-681-2045</phone>
      <email>megan.clowse@duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Laura Neil</last_name>
      <phone>919 684 8936</phone>
      <email>laura.k.neil@duke.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>September 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2017</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

